Bernicke Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$1.07M Sell
6,514
-3,563
-35% -$547K 0.79% 13
2020
Q1
$1.4M Buy
10,077
+135
+1% +$18.5K 0.85% 10
2019
Q4
$1.31M Buy
9,942
+397
+4% +$46K 0.73% 15
2019
Q3
$1.07M Buy
9,545
+1,015
+12% +$113K 0.62% 30
2019
Q2
$945K Buy
+8,530
New +$1M 0.57% 32
2017
Q3
Sell
-2,832
Closed -$233K 52
2017
Q2
$233K Sell
2,832
-2,920
-51% -$238K 0.19% 50
2017
Q1
$484K Sell
5,752
-5,513
-49% -$442K 0.4% 26
2016
Q4
$829K Sell
11,265
-473
-4% -$35.2K 0.72% 26
2016
Q3
$942K Sell
11,738
-35
-0.3% -$2.8K 0.82% 19
2016
Q2
$927K Buy
11,773
+38
+0.3% +$2.86K 0.84% 22
2016
Q1
$845K Buy
11,735
+518
+5% +$39.2K 0.78% 25
2015
Q4
$945K Hold
11,217
0.92% 16
2015
Q3
$939K Sell
11,217
-449
-4% -$37.9K 0.96% 16
2015
Q2
$974K Buy
11,666
+918
+9% +$69.9K 0.93% 16
2015
Q1
$781K Sell
10,748
-12,540
-54% -$893K 0.83% 26
2014
Q4
$1.61M Buy
+23,288
New +$1.57M 1.58% 16

Other funds holding LLY

Bernicke Wealth Management's LLY Position: Q2 2020 in Review

Bernicke Wealth Management reduced its Eli Lilly (LLY) stake by 35% in Q2 2020, selling an estimated $547K and leaving 6,514 shares worth $1.07M. The position accounts for 0.79% of the portfolio, ranked #13.

Bernicke Wealth Management first reported a position in LLY in Q4 2014 and has held it in 16 quarters since. The position peaked at $1.61M in Q4 2014. 1,765 funds tracked by Wall St. Rank hold LLY as of Q2 2020.

  • Bernicke Wealth Management held 6,514 shares of Eli Lilly worth $1.07M as of Q2 2020.
  • Bernicke Wealth Management sold 3,563 Eli Lilly shares in Q2 2020, an estimated $547K.
  • Eli Lilly made up 0.79% of Bernicke Wealth Management's portfolio in Q2 2020, its #13 holding.
  • Bernicke Wealth Management first reported a position in Eli Lilly in Q4 2014 and has held it in 16 quarters since.
  • Bernicke Wealth Management's Eli Lilly position peaked at $1.61M in Q4 2014.
  • 1,765 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2020.

Based on Bernicke Wealth Management's 13F filing for Q2 2020, filed 19 Aug 2020.